Episode 46: Mary Anne Urlakis interviews Dr. Alan Moy, founder of Cellular Engineering Technologies (CET) (March 12, 2024)

In this episode of Inter Vitam et Mortem, Dr. Mary Anne Urlakis
interviews Dr. Alan Moy, founder of Cellular Engineering
Technologies (CET) (March 12, 2024)

In 2005, Dr. Moy left his tenured academic career  to start a
private solo pulmonary practice at a nearby Catholic hospital and
started, on the same day, Cellular Engineering Technologies (CET),
a biotech company with a modest goal of manufacturing adult stem
cels. In 2006, he founded the non-profit John Paul II Medical
Research Institute (JP2MRI). Initially the mission was to educate
society on pro-life medical research ethics and advocate for the US
to pursue adult stem cell research. 

CET/JP2MRI developed biotechnology that is now superior and has the
future potential to replace embryonic stem cells and aborted fetal
cells that now commonly are used in the biopharmaceutical industry.
While this change will not occur overnight, the scientific and
business foundation is in place to support this vision. See the
paper that was published in the Linacre Quarterly that describes
Dr. Moy's journey. 
https://pubmed.ncbi.nlm.nih.gov/32549639/

Dr. Moy was recently asked to publish a paper on the challenges of
induced pluripotent stem cells for the European Medical Society.
 https://pubmed.ncbi.nlm.nih.gov/38188933/

Both CET/JP2MRI are at an inflection point in their science and
business to take off and hopefully achieve the vision that Dr. Moy
started 2 decades ago.  

Dr. Moy recently published an honest criticism directed towards
Catholic and pro-life institutions.
 https://thefederalist.com/2024/02/12/this-one-abortion-story-changed-medicine-forever-but-pro-lifers-hardly-talk-about-it/